Related Experiment Video

Updated: Jun 3, 2026

Flow Cytometry Analysis of Immune Cells Within Murine Aortas
15:15

Flow Cytometry Analysis of Immune Cells Within Murine Aortas

Published on: July 1, 2011

Inflammation in atherosclerosis and implications for therapy

Rodolfo Paoletti1, Antonio M Gotto, David P Hajjar

  • 1Department of Pharmacological Sciences, University of Milan, via Balzaretti 9, 20133, Milan, Italy. rodolfo.paoletti@unimi.it

Circulation
|June 17, 2004
PubMed

Insights

Atherosclerosis, an inflammatory disease, leads to serious complications like heart attack and stroke. Targeting inflammation offers a promising therapeutic strategy for preventing and treating this condition.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Pathology

Background:

  • Atherosclerosis is recognized as an inflammatory disease.
  • Complications include ischemia, acute coronary syndromes, and stroke.
  • Inflammation may stem from oxidized low-density lipoproteins or chronic infections.

Purpose of the Study:

  • To highlight the role of inflammation in atherosclerosis.
  • To discuss the potential of targeting inflammatory processes therapeutically.
  • To emphasize the predictive value of inflammatory markers like C-reactive protein for coronary heart disease risk.

Main Methods:

  • Review of current understanding of atherosclerosis pathogenesis.
  • Analysis of the link between inflammation and cardiovascular events.
  • Discussion of potential therapeutic targets based on inflammatory pathways.

Main Results:

  • Inflammation is a key characteristic of atherosclerosis.
  • Markers like C-reactive protein can indicate increased coronary heart disease risk.
  • Oxidized LDL and chronic infections are potential triggers for inflammation.

Conclusions:

  • Inflammatory processes are central to atherosclerosis and its complications.
  • Therapeutic strategies targeting inflammation may prevent and treat atherosclerosis.
  • Further research into anti-inflammatory therapies for cardiovascular disease is warranted.

More Related Videos

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...